We have recently designed and synthesized a TR ligand (GC-1) representative of a new class of thyromimetics that has several synthetic advantages over traditional thyromimetics and interesting, potentially useful, thyromimetic properties. Currently, no high affinity antagonist is known for TR, but such a ligand could prove very useful in medicine for treatment of hyperthyroidism and, possibly, cardiac arrhytmia, as well as the study of thyroid hormone signaling pathways. A comparison of the structures of many nuclear receptor agonists and antagonists shows an interesting trend: the antagonists all have the general skeleton of the corresponding agonists plus a large """"""""extension"""""""" protruding from the approximate center of the molecule. The recently solved crystal structures of the estrogen receptor complexed with the ER agonist estradiol and with the antagonist raloxifene show that, as a result of the presence of the extension, raloxifene binding impairs receptor folding and prevents the agonist-induced conformational changes in the receptor. The GC-1 thyromimetic scaffold is well suited to generate analogues, several sites are especially amenable of derivatization chemistry. The crystal structures of the ligand binding domains of both TR subtypes (alpha and beta) have been solved. Visual inspection of these structures with the program MidasPlus and using the Computer Graphics Laboratory facilities play an essential role in our effort to make a TR antagonist.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
3P41RR001081-22S1
Application #
6220219
Study Section
Project Start
1999-07-01
Project End
2000-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
22
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Kozak, John J; Gray, Harry B; Garza-López, Roberto A (2018) Relaxation of structural constraints during Amicyanin unfolding. J Inorg Biochem 179:135-145
Alamo, Lorenzo; Pinto, Antonio; Sulbarán, Guidenn et al. (2018) Lessons from a tarantula: new insights into myosin interacting-heads motif evolution and its implications on disease. Biophys Rev 10:1465-1477
Viswanath, Shruthi; Chemmama, Ilan E; Cimermancic, Peter et al. (2017) Assessing Exhaustiveness of Stochastic Sampling for Integrative Modeling of Macromolecular Structures. Biophys J 113:2344-2353
Chu, Shidong; Zhou, Guangyan; Gochin, Miriam (2017) Evaluation of ligand-based NMR screening methods to characterize small molecule binding to HIV-1 glycoprotein-41. Org Biomol Chem 15:5210-5219
Portioli, Corinne; Bovi, Michele; Benati, Donatella et al. (2017) Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications. J Biomed Mater Res A 105:847-858
Alamo, Lorenzo; Koubassova, Natalia; Pinto, Antonio et al. (2017) Lessons from a tarantula: new insights into muscle thick filament and myosin interacting-heads motif structure and function. Biophys Rev 9:461-480
Nguyen, Hai Dang; Yadav, Tribhuwan; Giri, Sumanprava et al. (2017) Functions of Replication Protein A as a Sensor of R Loops and a Regulator of RNaseH1. Mol Cell 65:832-847.e4
Sofiyev, Vladimir; Kaur, Hardeep; Snyder, Beth A et al. (2017) Enhanced potency of bivalent small molecule gp41 inhibitors. Bioorg Med Chem 25:408-420
Nekouzadeh, Ali; Rudy, Yoram (2016) Conformational changes of an ion-channel during gating and emerging electrophysiologic properties: Application of a computational approach to cardiac Kv7.1. Prog Biophys Mol Biol 120:18-27
Towse, Clare-Louise; Vymetal, Jiri; Vondrasek, Jiri et al. (2016) Insights into Unfolded Proteins from the Intrinsic ?/? Propensities of the AAXAA Host-Guest Series. Biophys J 110:348-361

Showing the most recent 10 out of 508 publications